Education
About Us
Working with TipRanks
Follow Us
GoodRx Holdings (GDRX)
NASDAQ:GDRX
GDRX Stock Chart & Stats
$2.72
-$0.12(-2.72%)
At close: 4:00 PM EST
$2.72
-$0.12(-2.72%)
Day’s Range― - ―
52-Week Range$2.61 - $5.81
Previous CloseN/A
Volume261.88K
Average Volume (3M)2.50M
Market Cap
$919.86M
Enterprise Value$1.74B
Total Cash (Recent Filing)$273.53M
Total Debt (Recent Filing)$545.13M
Price to Earnings (P/E)31.5
Beta0.87
Next Earnings
Feb 26, 2026EPS Estimate
0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.08
Shares Outstanding105,468,834
10 Day Avg. Volume1,629,676
30 Day Avg. Volume2,500,510
Financial Highlights & Ratios
PEG Ratio-0.37
Price to Book (P/B)2.48
Price to Sales (P/S)2.26
P/FCF Ratio15.80
Enterprise Value/Market Cap1.89
Enterprise Value/Revenue2.18
Enterprise Value/Gross Profit2.39
Enterprise Value/Ebitda9.89
Forecast
1Y Price Target
$4.75Price Target Upside74.63% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering11
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Expansion And GrowthGoodRx expands partnership with Kroger to offer branded drugs at a discounted price through RxSmartSaver, available in 2,200 pharmacies across 35 states.
New Revenue StreamsThe subscription offering creates new revenue streams that can help stabilize revenue growth over time.
Strategic PartnershipsGoodRx announced a partnership with Novo Nordisk to offer an introductory cash price of $199 per month for Ozempic and Wegovy injection pens for GoodRx users.
Bears Say
Competitive ChallengesSignificant competition in direct-to-consumer offerings like hair loss, sexual health, and weight loss could become a challenge for GDRX.
Market UncertaintyRecent market changes to pharmacy benefit manager contracts with plan sponsors add incremental uncertainty to GoodRx’s core business.
Pharmacy ClosuresBroader headwinds from pharmacy closures and reimbursement changes in the pharmacy ecosystem.
GoodRx Holdings News
GDRX FAQ
What was GoodRx Holdings’s price range in the past 12 months?
GoodRx Holdings lowest stock price was $2.61 and its highest was $5.81 in the past 12 months.
What is GoodRx Holdings’s market cap?
GoodRx Holdings’s market cap is $919.86M.
When is GoodRx Holdings’s upcoming earnings report date?
GoodRx Holdings’s upcoming earnings report date is Feb 26, 2026 which is in 78 days.
How were GoodRx Holdings’s earnings last quarter?
GoodRx Holdings released its earnings results on Nov 04, 2025. The company reported $0.08 earnings per share for the quarter, missing the consensus estimate of $0.09 by -$0.01.
Is GoodRx Holdings overvalued?
According to Wall Street analysts GoodRx Holdings’s price is currently Undervalued.
Does GoodRx Holdings pay dividends?
GoodRx Holdings does not currently pay dividends.
What is GoodRx Holdings’s EPS estimate?
GoodRx Holdings’s EPS estimate is 0.09.
How many shares outstanding does GoodRx Holdings have?
GoodRx Holdings has 105,468,834 shares outstanding.
What happened to GoodRx Holdings’s price movement after its last earnings report?
GoodRx Holdings reported an EPS of $0.08 in its last earnings report, missing expectations of $0.09. Following the earnings report the stock price went up 2.147%.
Which hedge fund is a major shareholder of GoodRx Holdings?
Currently, no hedge funds are holding shares in GDRX
GoodRx Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.75 (74.63% Upside)
$4.75 (74.63% Upside)
Blogger Sentiment
Bullish
GDRX Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 434.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $95.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 1.5%
Last 30 Days ▲ 3.2%
Last 30 Days ▲ 3.2%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-44.69%
12-Months-Change
Fundamentals
Return on Equity
4.90%
Trailing 12-Months
Asset Growth
-2.17%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
GoodRx Holdings
GoodRx Holdings, Inc. is a healthcare technology company that operates in the digital health sector, primarily focused on providing prescription drug price transparency and savings solutions. Through its platform, GoodRx enables consumers to compare prices for medications at various pharmacies, access coupons, and find discounts, ultimately aiming to make healthcare more affordable. The company's core products include its website and mobile applications that offer price comparisons, telehealth services, and pharmacy discount cards, catering to a wide range of consumers seeking to lower their prescription drug costs.
GDRX Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected a balanced view with significant growth in Manufacturer Solutions and brand partnerships, offset by declines in prescription transaction revenue due to external factors. The company is optimistic about future growth opportunities and strategic initiatives.View all GDRX earnings summariesGDRX Revenue Breakdown
73.41% Prescription transactions
12.58% Subscription
11.34% Pharma manufacturer solutions
2.67% Other
GDRX Stock 12 Month Forecast
Average Price Target
$4.75
▲(74.63% Upside)
Technical Analysis
Ownership Overview
11.65% Insiders
12.05% Mutual Funds
7.66% Other Institutional Investors
57.99% Public Companies and Individual Investors